Skip Navigation


Hum. Reprod. Advance Access originally published online on August 11, 2005
Human Reproduction 2005 20(12):3452-3458; doi:10.1093/humrep/dei241
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
20/12/3452    most recent
dei241v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ziyyat, A.
Right arrow Articles by Wolf, J.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ziyyat, A.
Right arrow Articles by Wolf, J.P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Cyclic FEE peptide increases human gamete fusion and potentiates its RGD-induced inhibition

A. Ziyyat1, N. Naud-Barriant1, V. Barraud-Lange1, F. Chevalier1, O. Kulski1, T. Lemkecher1, M. Bomsel2 and J.P. Wolf1,3

1 Laboratoire de Biologie de la Reproduction, UPRES 3410, UFR SMBH, Université Paris 13, 74, rue Marcel Cachin, 93017 Bobigny, Service d’Histologie-Embryologie-Cytogénétique, Hôpital Jean Verdier (Assistance Publique-Hôpitaux de Paris), Bondy and 2 Laboratoire ‘Entrée muqueuse du VIH et immunité muqueuse’, Unité INSERM U567, Institut Cochin, 22, rue Méchain, 75014 Paris, France

3 To whom correspondence should be addressed. E-mail: jean-philippe.wolf{at}jvr.ap-hop-paris.fr

BACKGROUND: {alpha}6{beta}1 integrin has been proposed to act as a sperm receptor on the mouse oocyte by interacting with spermatozoon fertilin {beta}. We investigated, in humans, whether oocyte integrins could act similarly in gamete fusion, using a cyclic peptide containing the putative disintegrin-binding domain of human fertilin {beta} [cyclic FEE (cFEE)] and RGD peptide. METHODS: Zona-free eggs were inseminated in the absence or presence of peptides. To maintain the membrane protein pattern, the zona pellucida was removed by microdissection. Immunofluorescence and confocal microscopy were used to detect integrin subunits on the oocyte. RESULTS: Unexpectedly, cFEE alone increased human gamete fusion by 94% instead of inhibiting fertilization. Furthermore, cFEE together with RGD potentiated the RGD-induced inhibition of fertilization in a dose-dependent manner. The data suggested the hypothesis of integrin cross-talk, further supported by the co-localization of {alpha}6{beta}1 and {alpha}v{beta}3 integrins, the putative receptors of cFEE and RGD peptides, respectively. CONCLUSIONS: RGD-sensitive and -insensitive integrins may be associated in a multimolecular complex working as a sperm receptor on the human oocyte membrane. Supplementation of human IVF culture medium with cFEE peptide might improve fertilization rates in ART.

Key words: FEE/fertilization/human/integrins/RGD


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.